|
OSBPL1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.526400E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.6497999995363E-07 |
| Normal-vs-Stage2 |
3.250300E-02 |
| Normal-vs-Stage3 |
7.224200E-02 |
| Normal-vs-Stage4 |
2.419600E-02 |
| Stage1-vs-Stage2 |
8.586600E-01 |
| Stage1-vs-Stage3 |
1.98730000011693E-07 |
| Stage1-vs-Stage4 |
1.84060000019137E-07 |
| Stage2-vs-Stage3 |
4.684000E-03 |
| Stage2-vs-Stage4 |
1.820690E-03 |
| Stage3-vs-Stage4 |
4.717800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.848050E-02 |
| Normal-vs-AfricanAmerican |
7.252200E-01 |
| Normal-vs-Asian |
8.119600E-01 |
| Caucasian-vs-AfricanAmerican |
9.524400E-02 |
| Caucasian-vs-Asian |
8.883600E-01 |
| AfricanAmerican-vs-Asian |
6.535400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.933400E-01 |
| Normal-vs-Female |
8.661700E-03 |
| Male-vs-Female |
1.372450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.958000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.483700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.709000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.044400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.277570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.921000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.477600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.955500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.193800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.868000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.319000E-03 |
| Normal-vs-Grade 2 |
3.37549999951392E-07 |
| Normal-vs-Grade 3 |
8.953200E-01 |
| Normal-vs-Grade 4 |
2.26079999999795E-05 |
| Grade 1-vs-Grade 2 |
6.475600E-02 |
| Grade 1-vs-Grade 3 |
9.89500000000421E-05 |
| Grade 1-vs-Grade 4 |
2.4336000004066E-07 |
| Grade 2-vs-Grade 3 |
2.48749999998132E-06 |
| Grade 2-vs-Grade 4 |
2.5088042754362E-11 |
| Grade 3-vs-Grade 4 |
4.06179999999923E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.7715611723761E-16 |
| Normal-vs-ccB subtype |
1.563580E-03 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.677800E-01 |
| Normal-vs-N1 |
8.073700E-02 |
| N0-vs-N1 |
4.430400E-02 |
|
|
